The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery

European Journal of Cardio-thoracic Surgery

Volumn 47, Issue 2, 2014, Pages 218-226

  Hogan, Maurice ^a   Klein, Andrew A ^a   Richards, Toby ^b  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anaemia; Cardiovascular surgery; Mortality; Postoperative recovery; Transfusion

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CARDIAC PATIENT; COHORT ANALYSIS; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; IRON THERAPY; LENGTH OF STAY; MORBIDITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; SUBSTITUTION THERAPY; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL; ADVERSE EFFECTS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANEMIA; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE TRANSFUSION; HUMANS; IRON; LENGTH OF STAY; PREVALENCE; TREATMENT OUTCOME;

EID: 84925354012     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu200     Document Type: Article

References (72)

1. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organisation. 2011 (WHO/NMH/NHD/MNM/11.1; http://who.int.vmnis/indicators/haemoglobin.pdf, 22 December 2013, date last accessed).
2. WHO. Global anaemia prevalence and number of individuals affected. http://www.who.int/vmnis/anaemia/prevalence/summary/anaemia_data_ statust2/en/index.html.
3. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011;378:1396-407.
4. Loor G, Koch CG, Sabik JF III, Li L, Blackstone EH. Implications and management of anemia in cardiac surgery: current state of knowledge. J Thorac Cardiovasc Surg 2012;144:538-46.
5. Mohnle P, Snyder-Ramos SA, Miao Y, Kulier A, Bottiger BW, Levin J et al. Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients. Intensive Care Med 2011;37: 97-109.
6. van Straten AH, Hamad MA, van Zundert AJ, Martens EJ, Schonberger JP, de Wolf AM. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation 2009;120:118-25.
7. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011-23.
8. Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, Mendonca M et al. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol 2013; 168:1997-2002.
9. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-48.
10. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 2002;16:87-96.
11. Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut 2011;60:1309-16.
12. Sanders J, Patel S, Cooper J, Berryman J, Farrar D, Mythen M et al. Red blood cell storage is associated with length of stay and renal complications after cardiac surgery. Transfusion 2011;51:2286-94.
13. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340: 409-17.
14. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012;147:49-55.
15. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116: 2544-52.
16. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Chan CT, Wong PY et al. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial. Anesthesiology 2012;116:613-21.
17. Vallet B, Futier E. Perioperative oxygen therapy and oxygen utilization. Curr Opin Crit Care 2010;16:359-64.
18. Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 2005;35:36-40.
19. Lidder PG, Sanders G, Whitehead E, Douie WJ, Mellor N, Lewis SJ et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery-a prospective, randomised, controlled trial. Ann R Coll Surg Engl 2007;89:418-21.
20. Ganzoni AM. Reticulocytes and plasma iron turnover in man. Eur J Clin Invest 1970;1:84-9.
21. Jensen NM, Brandsborg M, Boesen AM, Yde H, Dahlerup JF. Low-dose oral iron absorption test in anaemic patients with and without iron deficiency determined by bone marrow iron content. Eur J Haematol 1999; 63:103-11.
22. Liguori L. Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients. Int J Clin Pharmacol Ther Toxicol 1993;31:103-23.
23. Coplin M, Schuette S, Leichtmann G, Lashner B. Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate. Clin Ther 1991;13: 606-12.
24. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion 2008; 48:988-1000.
25. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1225-7.
26. Usmanov RI, Zueva EB, Silverberg DS, Shaked M. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol 2008;21:236-42.
27. Breymann C, Richter C, Huttner C, Huch R, Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest 2000;30:154-61.
28. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007;110: 267-78.
29. Wagstrom E, Akesson A, Van Rooijen M, Larson B, Bremme K. Erythropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstet Gynecol Scand 2007;86:957-62.
30. Agarwal R, Rizkala AR, Bastani B, Kaskas MO, Leehey DJ, Besarab A. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease. Am J Nephrol 2006;26:445-54.
31. Gotloib L, Silverberg D, Fudin R, Shostak A. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol 2006;19:161-7.
32. Theusinger OM, Leyvraz PF, Schanz U, Seifert B, Spahn DR. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 2007;107:923-7.
33. Schroder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005;100:2503-9.
34. Gupta A, Crumbliss AL. Treatment of iron deficiency anemia: are monomeric iron compounds suitable for parenteral administration? J Lab Clin Med 2000;136:371-8.
35. Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol 2010;55:2024-33.
36. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. http://www.cochrane-handbook.org
37. Elmistekawy E, Rubens F, Hudson C, McDonald B, Ruel M, Lam K et al. Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. Eur J Cardiothorac Surg 2013;44:1051-5; discussion 55-6.
38. Williams ML, He X, Rankin JS, Slaughter MS, Gammie JS. Preoperative hematocrit is a powerful predictor of adverse outcomes in coronary artery bypass graft surgery: a report from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2013;96:1628-34; discussion 34.
39. van Straten AH, Kulcu K, Ozdemir HI, Elenbaas TW, Soliman Hamad MA. Preoperative hemoglobin level as a predictor of mortality after aortic valve replacement. J Cardiothorac Vasc Anesth 2013;27:716-22.
40. Piednoir P, Allou N, Driss F, Longrois D, Philip I, Beaumont C et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. Eur J Anaesthesiol 2011;28:796-801.
41. Carrascal Y, Maroto L, Rey J, Arevalo A, Arroyo J, Echevarria JR et al. Impact of preoperative anemia on cardiac surgery in octogenarians. Interact CardioVasc Thorac Surg 2010;10:249-55.
42. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007;116:471-9.
43. Boening A, Boedeker RH, Scheibelhut C, Rietzschel J, Roth P, Schonburg M. Anemia before coronary artery bypass surgery as additional risk factor increases the perioperative risk. Ann Thorac Surg 2011;92:805-10.
44. De Santo L, Romano G, Della Corte A, de Simone V, Grimaldi F, Cotrufo M et al. Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury. J Thorac Cardiovasc Surg 2009;138: 965-70.
45. Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002; 359:1747-8.
46. Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008;117:478-84.
47. Hung M, Besser M, Sharples LD, Nair SK, Klein AA. The prevalence and association with transfusion, intensive care unit stay and mortality of preoperative anaemia in a cohort of cardiac surgery patients. Anaesthesia 2011;66:812-8.
48. Bell ML, Grunwald GK, Baltz JH, McDonald GO, Bell MR, Grover FL et al. Does preoperative hemoglobin independently predict short-term outcomes after coronary artery bypass graft surgery? Ann Thorac Surg 2008; 86:1415-23.
49. Cladellas M, Bruguera J, Comin J, Vila J, de Jaime E, Marti J et al. Is preoperative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? Eur Heart J 2006;27:1093-9.
50. Ranucci M, Di Dedda U, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. Ann Thorac Surg 2012;94:1134-41.
51. Matsuda S, Fukui T, Shimizu J, Takao A, Takanashi S, Tomoike H. Associations between preoperative anemia and outcomes after off-pump coronary artery bypass grafting. Ann Thorac Surg 2013;95:854-60.
52. Cladellas M, Farre N, Comin-Colet J, Gomez M, Merono O, Bosch MA et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol 2012;110:1021-6.
53. Madi-Jebara SN, Sleilaty GS, Achouh PE, Yazigi AG, Haddad FA, Hayek GM et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004;18:59-63.
54. Garrido-Martin P, Nassar-Mansur MI, de la Llana-Ducros R, Virgos-Aller TM, Rodriguez Fortunez PM, Avalos-Pinto R et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact CardioVasc Thorac Surg 2012;15:1013-8.
55. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006;53:11-9.
56. Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013;96:478-85.
57. Crosby L, Palarski VA, Cottington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart Lung 1994;23:493-9.
58. Karski JM, Mathieu M, Cheng D, Carroll J, Scott GJ. Etiology of preoperative anemia in patients undergoing scheduled cardiac surgery. Can J Anaesth 1999;46:979-82.
59. Grey DE, Smith V, Finlayson J. Iron studies and red cell transfusion in cardiothoracic and orthopaedic surgical patients: a retrospective audit at a tertiary hospital. Vox Sang 2012;102:150-8.
60. Munoz M, Garcia-Erce JA, Diez-Lobo AI, Campos A, Sebastianes C, Bisbe E. Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients. Med Clin (Barc) 2009;132:303-6.
61. Shander A, Spence RK, Auerbach M. Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents? Transfusion 2010;50:719-32.
62. Serrano-Trenas JA, Ugalde PF, Cabello LM, Chofles LC, Lazaro PS, Benitez PC. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion 2011;51: 97-104.
63. Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 2005;125:342-7.
64. Cuenca J, Garcia-Erce JA, Munoz M, Izuel M, Martinez AA, Herrera A. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004;44:1447-52.
65. Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008;100:599-604.
66. Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 2012;14:423-9.
67. Wells PS. Safety and efficacy of methods for reducing perioperative allogeneic transfusion: a critical review of the literature. Am J Ther 2002;9:377-88.
68. Stone GW, Clayton TC, Mehran R, Dangas G, Parise H, Fahy M et al. Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Am Heart J 2012;163:522-9.
69. Scott BH, Seifert FC, Grimson R. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth 2008;11:15-9.
70. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010;14:Cd001888.
71. Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063-70.
72. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;17:Cd001886.